ICL and Lavie Bio Enter Strategic Collaboration to Develop Novel Bio-Stimulant Products
17 August 2022, Israel: ICL, a leading global specialty minerals company, and Evogene Ltd., a leading computational biology company focused on
Read More
Evogene
Lavie Bio Announces Successful Product Launch of its Bio-Inoculant result™ for the 2022 Spring Wheat Growing Season
12 May 2022, Israel: Lavie Bio Ltd., a subsidiary of Evogene Ltd., (NASDAQ: EVGN, TASE: EVGN) and a leading ag-biologicals company
Read More
Evogene to Attend to World Agri-Tech Innovation Summit from March 22-23, 2022
08 March 2021, Israel: Evogene Ltd. (NASDAQ: EVGN, TASE: EVGN), a leading computational biology company focused on revolutionizing product discovery and
Read More
Evogene to Attend the 34th Annual ROTH Investor Conference in Dana Point California Between March 13-15, 2022
05 March 2022, Israel: Evogene Ltd., a leading computational biology company focused on revolutionizing product discovery and development in multiple life-science
Read More
Canonic Announces Shipment of its Cannabis Varieties to Europe
01 February 2022, Israel: Canonic Ltd., focused on the development of medical grade cannabis products and a wholly-owned subsidiary of Evogene
Read More
Lavie Bio Reports Advancement in its Bio-Fungicide Program for Fruit Rots
Advancement to the pre-commercial stage follows positive results from three consecutive years of vineyard trials for fruit rot diseases 15 December
Read More
Evogene Reports Third Quarter 2021 Financial Results
19 November 2021, Israel: Evogene Ltd., a leading computational biology company targeting to revolutionize life-science product discovery and development across
Read More
Evogene Announces Participation in the Second Research Period of the CRISPR-IL Consortium
14 November 2021, Israel: Evogene Ltd., a leading computational biology company targeting to revolutionize life-science product development across several market segments,
Read More